138 related articles for article (PubMed ID: 37981531)
1. Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia.
Strøm TB; Tveita AA; Bogsrud MP; Leren TP
J Clin Lipidol; 2024; 18(1):e80-e89. PubMed ID: 37981531
[TBL] [Abstract][Full Text] [Related]
2. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins.
Adeyo O; Goulbourne CN; Bensadoun A; Beigneux AP; Fong LG; Young SG
J Intern Med; 2012 Dec; 272(6):528-40. PubMed ID: 23020258
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
Beigneux AP; Miyashita K; Ploug M; Blom DJ; Ai M; Linton MF; Khovidhunkit W; Dufour R; Garg A; McMahon MA; Pullinger CR; Sandoval NP; Hu X; Allan CM; Larsson M; Machida T; Murakami M; Reue K; Tontonoz P; Goldberg IJ; Moulin P; Charrière S; Fong LG; Nakajima K; Young SG
N Engl J Med; 2017 Apr; 376(17):1647-1658. PubMed ID: 28402248
[TBL] [Abstract][Full Text] [Related]
4. Chylomicronemia from GPIHBP1 autoantibodies.
Miyashita K; Lutz J; Hudgins LC; Toib D; Ashraf AP; Song W; Murakami M; Nakajima K; Ploug M; Fong LG; Young SG; Beigneux AP
J Lipid Res; 2020 Nov; 61(11):1365-1376. PubMed ID: 32948662
[TBL] [Abstract][Full Text] [Related]
5. GPIHBP1 and Plasma Triglyceride Metabolism.
Fong LG; Young SG; Beigneux AP; Bensadoun A; Oberer M; Jiang H; Ploug M
Trends Endocrinol Metab; 2016 Jul; 27(7):455-469. PubMed ID: 27185325
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-377 Inhibits Atherosclerosis by Regulating Triglyceride Metabolism Through the DNA Methyltransferase 1 in Apolipoprotein E-Knockout Mice.
Chen LY; Xia XD; Zhao ZW; Gong D; Ma XF; Yu XH; Zhang Q; Wang SQ; Dai XY; Zheng XL; Zhang DW; Yin WD; Tang CK
Circ J; 2018 Oct; 82(11):2861-2871. PubMed ID: 30232292
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL.
Larsson M; Allan CM; Jung RS; Heizer PJ; Beigneux AP; Young SG; Fong LG
J Lipid Res; 2017 Sep; 58(9):1893-1902. PubMed ID: 28694296
[TBL] [Abstract][Full Text] [Related]
8. A 3-day-old neonate with severe hypertriglyceridemia from novel mutations of the GPIHBP1 gene.
Buonuomo PS; Bartuli A; Rabacchi C; Bertolini S; Calandra S
J Clin Lipidol; 2015; 9(2):265-70. PubMed ID: 25911085
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein lipase transporter GPIHBP1 and triglyceride-rich lipoprotein metabolism.
Liu C; Li L; Guo D; Lv Y; Zheng X; Mo Z; Xie W
Clin Chim Acta; 2018 Dec; 487():33-40. PubMed ID: 30218660
[TBL] [Abstract][Full Text] [Related]
10. Role of glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in hypertriglyceridemia and diabetes.
Kurooka N; Eguchi J; Wada J
J Diabetes Investig; 2023 Oct; 14(10):1148-1156. PubMed ID: 37448184
[TBL] [Abstract][Full Text] [Related]
11. A protein of capillary endothelial cells, GPIHBP1, is crucial for plasma triglyceride metabolism.
Young SG; Song W; Yang Y; Birrane G; Jiang H; Beigneux AP; Ploug M; Fong LG
Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2211136119. PubMed ID: 36037340
[TBL] [Abstract][Full Text] [Related]
12. Structure of the lipoprotein lipase-GPIHBP1 complex that mediates plasma triglyceride hydrolysis.
Birrane G; Beigneux AP; Dwyer B; Strack-Logue B; Kristensen KK; Francone OL; Fong LG; Mertens HDT; Pan CQ; Ploug M; Young SG; Meiyappan M
Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1723-1732. PubMed ID: 30559189
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.
Vaziri ND; Yuan J; Ni Z; Nicholas SB; Norris KC
Clin Exp Nephrol; 2012 Apr; 16(2):238-43. PubMed ID: 22009636
[TBL] [Abstract][Full Text] [Related]
14. GPIHBP1, an endothelial cell transporter for lipoprotein lipase.
Young SG; Davies BS; Voss CV; Gin P; Weinstein MM; Tontonoz P; Reue K; Bensadoun A; Fong LG; Beigneux AP
J Lipid Res; 2011 Nov; 52(11):1869-84. PubMed ID: 21844202
[TBL] [Abstract][Full Text] [Related]
15. GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.
Hu X; Dallinga-Thie GM; Hovingh GK; Chang SY; Sandoval NP; Dang TLP; Fukamachi I; Miyashita K; Nakajima K; Murakami M; Fong LG; Ploug M; Young SG; Beigneux AP
J Clin Lipidol; 2017; 11(4):964-971. PubMed ID: 28666713
[TBL] [Abstract][Full Text] [Related]
16. GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism.
Young SG; Fong LG; Beigneux AP; Allan CM; He C; Jiang H; Nakajima K; Meiyappan M; Birrane G; Ploug M
Cell Metab; 2019 Jul; 30(1):51-65. PubMed ID: 31269429
[TBL] [Abstract][Full Text] [Related]
17. The g.-469G>A polymorphism in the GPIHBP1 gene promoter is associated with hypertriglyceridemia and has an additive effect on the risk conferred by LPL defective alleles.
Guay SP; Gaudet D; Brisson D
Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):358-65. PubMed ID: 21978733
[TBL] [Abstract][Full Text] [Related]
18. GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis.
Zhang G; Yang Q; Mao W; Hu Y; Pu N; Deng H; Yu X; Zhang J; Zhou J; Ye B; Li G; Li B; Ke L; Tong Z; Murakami M; Kimura T; Nakajima K; Cao W; Liu Y; Li W
J Clin Lipidol; 2022; 16(5):626-634. PubMed ID: 36064883
[TBL] [Abstract][Full Text] [Related]
19. AAV-mediated hepatic LPL expression ameliorates severe hypertriglyceridemia and acute pancreatitis in Gpihbp1 deficient mice and rats.
Yuan C; Xu Y; Lu G; Hu Y; Mao W; Ke L; Tong Z; Xia Y; Ma S; Dong X; Xian X; Wu X; Liu G; Li B; Li W
Mol Ther; 2024 Jan; 32(1):59-73. PubMed ID: 37974401
[TBL] [Abstract][Full Text] [Related]
20. Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis.
Xie SL; Chen TZ; Huang XL; Chen C; Jin R; Huang ZM; Zhou MT
PLoS One; 2015; 10(6):e0129488. PubMed ID: 26079787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
